Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1153060.RAO7xANI2SYacUnjtzOLfqpBrH6QCSzpjH5iPPqmsvdBk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1153060.RAO7xANI2SYacUnjtzOLfqpBrH6QCSzpjH5iPPqmsvdBk130_assertion type Assertion NP1153060.RAO7xANI2SYacUnjtzOLfqpBrH6QCSzpjH5iPPqmsvdBk130_head.
- NP1153060.RAO7xANI2SYacUnjtzOLfqpBrH6QCSzpjH5iPPqmsvdBk130_assertion description "[Interestingly, a potential gene fusion was also identified in amplified DDR2, which is a potential therapeutic target of kinase inhibitors such as dastinib, that are not routinely used in the treatment of patients with liposarcoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1153060.RAO7xANI2SYacUnjtzOLfqpBrH6QCSzpjH5iPPqmsvdBk130_provenance.
- NP1153060.RAO7xANI2SYacUnjtzOLfqpBrH6QCSzpjH5iPPqmsvdBk130_assertion evidence source_evidence_literature NP1153060.RAO7xANI2SYacUnjtzOLfqpBrH6QCSzpjH5iPPqmsvdBk130_provenance.
- NP1153060.RAO7xANI2SYacUnjtzOLfqpBrH6QCSzpjH5iPPqmsvdBk130_assertion SIO_000772 24505276 NP1153060.RAO7xANI2SYacUnjtzOLfqpBrH6QCSzpjH5iPPqmsvdBk130_provenance.
- NP1153060.RAO7xANI2SYacUnjtzOLfqpBrH6QCSzpjH5iPPqmsvdBk130_assertion wasDerivedFrom befree-2016 NP1153060.RAO7xANI2SYacUnjtzOLfqpBrH6QCSzpjH5iPPqmsvdBk130_provenance.
- NP1153060.RAO7xANI2SYacUnjtzOLfqpBrH6QCSzpjH5iPPqmsvdBk130_assertion wasGeneratedBy ECO_0000203 NP1153060.RAO7xANI2SYacUnjtzOLfqpBrH6QCSzpjH5iPPqmsvdBk130_provenance.